Tribunal upholds disallowance of LTCG on shares & addition of unexplained income.

The tribunal upheld the Assessing Officer's decision to disallow Long Term Capital Gain (LTCG) on the sale of shares of Kappac Pharma Limited due to discrepancies in share transactions, despite the assessee's claim of genuine transactions. Additionally, the tribunal affirmed the addition of tuition income as unexplained income under Section 68 of the Act, as the assessee failed to provide adequate documentation. The appeal was dismissed, and the additions made by the Assessing Officer were upheld based on the lack of concrete evidence and documentation supporting the transactions and income.

---

---

Issues:
1. Disallowance of Long Term Capital Gain (LTCG) on sale of shares of Kappac Pharma Limited.
2. Addition of tuition income as unexplained income under Section 68 of the Act.

Issue 1: Disallowance of LTCG on sale of shares of Kappac Pharma Limited:
The appeal was against the order confirming the addition of LTCG on the sale of shares of Kappac Pharma Limited. The Assessing Officer observed that the LTCG claimed by the assessee was denied due to suspicions regarding the genuineness of the share transactions. The CIT(A) upheld the addition. The assessee contended that the purchase and sale of shares were genuine, supported by valid documents, and met the conditions for claiming exemption under Section 10(38) of the Act. The assessee argued that the AO failed to provide concrete evidence of the alleged bogus LTCG transactions. However, the tribunal found discrepancies in the share transactions, noting that the purchase price was higher than the market price, indicating a potentially non-genuine nature of the transactions. Referring to a Delhi High Court decision on Kappac Pharma Limited scrip, the tribunal upheld the denial of LTCG exemption, dismissing the appeal.

Issue 2: Addition of tuition income as unexplained income:
The Assessing Officer treated the tuition income shown by the assessee as unexplained income under Section 68 of the Act. The CIT(A) affirmed this addition. The assessee argued that the income was genuine and supported by evidence, urging that it should not be treated as unexplained income. However, the tribunal found that the Assessing Officer had valid reasons for treating the tuition income as unexplained, as the assessee failed to provide sufficient documentation to support the income. Consequently, the tribunal upheld the addition of tuition income as unexplained income under Section 68 of the Act.

In conclusion, the tribunal dismissed the appeal filed by the assessee, upholding the additions made by the Assessing Officer regarding the LTCG on the sale of shares of Kappac Pharma Limited and the tuition income treated as unexplained income. The decision was based on the discrepancies found in the share transactions and the lack of adequate documentation supporting the tuition income, as determined by the Assessing Officer.

---